Standard BioTools (STU:FLB) E10: €-1.25 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:FLB Standard BioTools Inc STU:FLB
39 GF Score
Price €0.75
GF Value €0.46
Valuation Significantly Overvalued
! 5 Warning Signs
View Full Analysis

What is Standard BioTools E10?

Standard BioTools STU:FLB -6.29% 39 E10 is €-1.25 as of Mar. 2026. GuruFocus rates STU:FLB with a GF Score™ of 39/100 and a GF Value™ of €0.46 (Significantly Overvalued). The stock has 5 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Standard BioTools's adjusted earnings per share data for the three months ended in Mar. 2026 was €0.285. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is €-1.25 for the trailing ten years ended in Mar. 2026.

During the past 3 years, the average E10 Growth Rate was 4.80% per year. During the past 5 years, the average E10 Growth Rate was -0.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Standard BioTools was 16.60% per year. The lowest was -4.40% per year. And the median was 4.80% per year.

As of today (2026-07-14), Standard BioTools's current stock price is €0.745. Standard BioTools's E10 for the quarter that ended in Mar. 2026 was €-1.25. Standard BioTools's Shiller PE Ratio of today is .


Standard BioTools  (STU:FLB) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Standard BioTools E10 Related Terms


Standard BioTools E10 Historical Data

* Premium members only.

The historical data trend for Standard BioTools's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Standard BioTools E10 Chart

Standard BioTools Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only -1.30 -1.71 -1.76 -1.71 -1.29

Standard BioTools Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.51 -1.35 -1.33 -1.29 -1.25

STU:FLB vs SENS, TMCI, SGHT: E10 Comparison

For the Medical Devices subindustry, Standard BioTools's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Standard BioTools Shiller PE Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Standard BioTools's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Standard BioTools's Shiller PE Ratio falls into.


STU:FLB
39GF Score
Standard BioTools Inc STU:FLB
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Standard BioTools E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Standard BioTools's adjusted earnings per share data for the three months ended in Mar. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=0.285/330.2130*330.2130
=0.285

Current CPI (Mar. 2026) = 330.2130.

Standard BioTools Quarterly Data

per share eps CPI Adj_EPS
201606 -0.570 241.018 -0.781
201609 -0.606 241.428 -0.829
201612 -0.578 241.432 -0.791
201703 -0.552 243.801 -0.748
201706 -0.516 244.955 -0.696
201709 -0.386 246.819 -0.516
201712 -0.228 246.524 -0.305
201803 -0.276 249.554 -0.365
201806 -0.360 251.989 -0.472
201809 -0.326 252.439 -0.426
201812 -0.316 251.233 -0.415
201903 -0.389 254.202 -0.505
201906 -0.177 256.143 -0.228
201909 -0.173 256.759 -0.222
201912 -0.164 256.974 -0.211
202003 -0.208 258.115 -0.266
202006 -0.160 257.797 -0.205
202009 -0.068 260.280 -0.086
202012 -0.197 260.474 -0.250
202103 -0.210 264.877 -0.262
202106 -0.191 271.696 -0.232
202109 -0.153 274.310 -0.184
202112 -0.106 278.802 -0.126
202203 -0.899 287.504 -1.033
202206 -0.776 296.311 -0.865
202209 -0.374 296.808 -0.416
202212 -0.245 296.797 -0.273
202303 -0.196 301.836 -0.214
202306 -0.203 305.109 -0.220
202309 -0.253 307.789 -0.271
202312 -0.229 306.746 -0.247
202403 -0.248 312.332 -0.262
202406 -0.111 314.175 -0.117
202409 -0.063 315.301 -0.066
202412 -0.086 315.605 -0.090
202503 -0.065 319.799 -0.067
202506 -0.078 322.561 -0.080
202509 -0.077 324.800 -0.078
202512 0.043 324.054 0.044
202603 0.285 330.213 0.285

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of €-1.25 mean?
Standard BioTools (STU:FLB) has a E10 of €-1.25 as of Mar. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Standard BioTools and its competitors.
Is Standard BioTools' E10 too high?
Standard BioTools' current E10 is €-1.25. Overall, Standard BioTools has a GF Score™ of 39/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Standard BioTools' E10 compare to SENS and TMCI?
Standard BioTools' E10 of €-1.25 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Medical Devices & Instruments company?
A good E10 depends on the Medical Devices & Instruments industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Standard BioTools and its competitors. Standard BioTools's current E10 is €-1.25. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Standard BioTools stock overvalued right now?
Based on GuruFocus' analysis, Standard BioTools (STU:FLB) is currently considered Significantly Overvalued. The stock's GF Value™ is €0.46, compared to a current price of €0.75 — trading 62% above its estimated fair value. The current E10 is €-1.25. Standard BioTools' overall GF Score™ is 39/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For Standard BioTools (STU:FLB), the current E10 is €-1.25 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Standard BioTools (STU:FLB) Overvalued in 2026?

Based on GuruFocus' analysis, Standard BioTools stock appears to be overvalued. The current stock price of €0.75 is trading 62% above its estimated GF Value™ of €0.46. GuruFocus considers Standard BioTools to be Significantly Overvalued.

Key valuation signals for STU:FLB:

  • E10: €-1.25
  • GF Value™: €0.46 vs. price of €0.75 (62% above fair value)
  • GF Score™: 39/100 with 5 warning signs

No single metric tells the full story. See the STU:FLB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Standard BioTools Business Description

Other Exchanges LAB:USA
Address 50 Milk Street, 10th Floor, Boston, MA, USA, 02109
Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. The company operates in one segment. Its technology includes: Genomics; Single-cell proteomics; Spatial proteomics. Its platforms include: Biomark X9 System, CyTOF XT system, and Hyperion XTi Imaging System. The company offers a diverse range of instrumentation, consumables, and services that generate high-quality data across early discovery, translational and clinical research. Geographically, it operates in Americas; EMEA and Asia-Pacific.
39GF Score

Get the complete analysis for STU:FLB

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.75
Price
€0.46
GF Value